患有严重肺部疾病的儿童的COVID-19 - 丹麦第三级中心队列研究
Esben Lægsgaard1, Signe Bødker Thim1, Mette Holm2
1Department of Child and Adolescent Health, Center of Pediatric Pulmonology and Allergology, Aarhus University Hospital, Aarhus, Denmark.
Pediatric pulmonology
|April 17, 2025
概括
患有严重肺病的儿童,包括慢性肺病 (CPD),喘和囊性纤维化 (CF),没有增加严重的COVID-19风险. 没有需要住院治疗,这表明这组儿科患者的严重后果风险并不高.
科学领域:
- 儿科肺病学 儿科肺病学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 患有慢性肺病 (CPD),喘和囊性纤维化 (CF) 等严重肺病的儿童面临严重COVID-19的更高风险.
- 关于这些儿科患者的SARS-CoV-2感染和COVID-19严重程度的数据有限.
研究的目的:
- 为了确定SARS-CoV-2感染在患有严重肺部疾病的未接种疫苗的儿童中的发生率.
- 为了评估COVID-19在这个儿科队列中的严重程度.
主要方法:
- 研究了一组664名患有严重肺部疾病的儿童.
- 通过PCR和抗体测试确定了SARS-CoV-2感染.
- 数据来自丹麦微生物学数据库和电子健康记录.
主要成果:
- 在594名测试儿童中,有18名 (3%) 确诊感染了SARS-CoV-2,与一般人群没有显著差异.
- 症状从无症状到轻度不等.
- 在这个队列中没有观察到住院或严重的COVID-19结局.
结论:
- 在这个丹麦队列中,患有严重肺病的儿童没有因为COVID-19而增加住院的风险.
- 这些发现表明,儿童严重的肺部疾病并不等同于患重症COVID-19的更高风险.
相关概念视频
Lung Capacity
47.9K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
47.9K
COPD: Pathogenesis and Clinical Features
174
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
174
COPD: Management Using Bronchodilators and Corticosteroids
123
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
123
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.4K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Acute Respiratory Failure-II
139
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
139


